68
|
277
|
3lokA |
Drug resistant csrc kinase domain in complex with covalent inhibitor pd168393 |
153
|
479
|
3lijA |
Crystal structure of full length cpcdpk3 (cgd5_820) in complex with ca2+ and amppnp |
111
|
350
|
3lfeA |
Human p38 map kinase in complex with rl116 |
107
|
350
|
3lfaA |
Human p38 map kinase in complex with dasatinib |
83
|
294
|
3le6A |
The structure of cyclin dependent kinase 2 (ckd2) with a pyrazolobenzodiazepine inhibitor |
89
|
284
|
3lm5A |
Crystal structure of human serine/threonine kinase 17b (stk17b) in complex with quercetin |
78
|
298
|
3lfqA |
Crystal structure of cdk2 with sar60, an aminoindazole type inhibitor |
128
|
347
|
3lq3A |
Crystal structure of human choline kinase beta in complex with phosphorylated hemicholinium-3 and adenosine nucleotide |
68
|
253
|
3lmiA |
Crystal structure of the inactive alpha-kinase domain of myosin heavy chain kinase a (d766a) complex with atp |
113
|
427
|
3lj2A |
Ire1 complexed with jak inhibitor i |
85
|
287
|
3lm0A |
Crystal structure of human serine/threonine kinase 17b (stk17b) |
103
|
350
|
3lfbA |
Human p38 map kinase in complex with rl98 |
107
|
341
|
3lltA |
Crystal structure of pf14_0431, kinase domain. |
78
|
322
|
3lq5A |
Structure of cdk9/cyclint in complex with s-cr8 |
113
|
327
|
3kxnA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor tetraiodobenzimidazole (k88) |
89
|
319
|
3lcoA |
Inhibitor bound to a dfg-out structure of the kinase domain of csf-1r |
106
|
337
|
3l9nA |
Crystal structure of pkab3 (pka triple mutant v123a, l173m, q181k) with compound 27 |
90
|
309
|
3ky2A |
Crystal structure of fibroblast growth factor receptor 1 kinase domain |
101
|
356
|
3kvxA |
Jnk3 bound to aminopyrimidine inhibitor, sr-3562 |
103
|
304
|
3lcsA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
103
|
308
|
3l9pA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
109
|
326
|
3kxmA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor k74 |
82
|
264
|
3kxzA |
The complex crystal structure of lck with a probe molecule w259 |
92
|
271
|
3lckA |
The kinase domain of human lymphocyte kinase (lck), activated form (auto-phosphorylated on tyr394) |
107
|
340
|
3l9lA |
Crystal structure of pka with compound 36 |
102
|
308
|
3lctA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
93
|
297
|
3lcdA |
Inhibitor bound to a dfg-in structure of the kinase domain of csf-1r |
98
|
349
|
3l8xA |
P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor |
109
|
327
|
3kxgA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64) |
181
|
642
|
3krxA |
Human grk2 in complex with gbetgamma subunits and balanol (co-crystal) |
94
|
360
|
3l1sA |
3-aryl-4-(arylhydrazono)-1h-pyrazol-5-ones: highly ligand efficient and potent inhibitors of gsk3 |
82
|
307
|
3l8vA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a biarylamine based inhibitor |
87
|
274
|
3kulA |
Kinase domain of human ephrin type-a receptor 8 (epha8) |
85
|
305
|
3kxxA |
Structure of the mutant fibroblast growth factor receptor 1 |
125
|
408
|
3kvwA |
Crystal structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (dyrk2) in complex with an indirubin ligand |
194
|
642
|
3krwA |
Human grk2 in complex with gbetgamma subunits and balanol (soak) |
109
|
340
|
3l9mA |
Crystal structure of pkab3 (pka triple mutant v123a, l173m, q181k) with compound 18 |
89
|
308
|
3l8pA |
Crystal structure of cytoplasmic kinase domain of tie2 complexed with inhibitor cep11207 |
108
|
327
|
3kxhA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl-acetic acid (k66) |
160
|
464
|
3ku2A |
Crystal structure of inactivated form of cdpk1 from toxoplasma gondii, tgme49.101440 |
69
|
297
|
3kexA |
Crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (her3) |
92
|
318
|
3ka0A |
Mk2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide |
82
|
237
|
3kreA |
Crystal structure of phosphoribosylaminoimidazole-succinocarboxamide synthase from ehrlichia chaffeensis at 1.8a resolution |
86
|
315
|
3kn5A |
Crystal structure of the c-terminal kinase domain of msk1 in complex with amp-pnp |
83
|
282
|
3kk9A |
Camkii substrate complex b |
78
|
268
|
3kmwA |
Crystal structure of the ilk/alpha-parvin core complex (mgatp) |
105
|
338
|
3kkvA |
Structure of pka with a protein kinase b-selective inhibitor. |
104
|
348
|
3kf7A |
Crystal structure of human p38alpha complexed with a triazolopyrimidine compound |
87
|
318
|
3krjA |
Cfms tyrosine kinase in complex with 4-cyano-1h-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide |
76
|
264
|
3kl8A |
Camkiintide inhibitor complex |